Read before blind bash-back. Right or wrong, neither jared's character or background, nor his managerial or marketing skills have much to do with my analysis of intrinsic value, so don't confuse this as personal smearing or baseless hating.
EESO does exist. It mixes several simple and readily available enzyme solutions together, primarily into Wowgreen bottles. I've never doubted that. It's using the owner's personal contacts and legwork to land it's initial commercial sales in a range of markets (here and abroad). That's great, it may well be among "the best 0.5% of companies with real products on the pinks", as Jared claimed.
But the equity value?
I'm a born skeptic, not a basher, but still can't believe what I'm hearing. Figured the trance would wear off after a declined $200 million offer by an unnamed company for an unaudited company with a "trade secret" and a mixing line.
A conference call later and the people are discussing a "good" buyout range of $1-6 billion, but would "be happy" for $500 million? Who's selling 100's of millions of shares against that? Does that resistance represent dumb money new to the game, flippers and irrational cynics?
Again, what's the common equity worth? What is the value of one non-voting, non-dividend, two-billionth of an unknown equity portion of an unknown net income? Drop in your own numbers, I did.
I won't bias you with my assumptions, which range from conservative "slow-and-steady" to wishful "out-of-the-park". People here seem to get squeemish and defensive when asked about valuation levers like time to projected regulatory approvals, channel sizes and penetration rates, let alone future capitalization required to scale or purchase capacity sufficient to meet those projected sales and growth rates (among other things).
Just my 2 cents, forgive me if you're looking for change (hint).
Market Data 
Markets 
AI
